On March 20, 2014, the Ontario Securities Commission (OSC) and the securities regulators in six other provinces published for comment proposed prospectus exemptions.
March 26, 2014
Over the past year, there were a number of notable developments relating to branding and naming of pharmaceutical products in Canada.
In 2010, the provinces and territories announced the creation the Pan-Canadian Pricing Alliance (“PCPA”). The PCPA is an initiative aimed at joint negotiations on..
March 25, 2014
On March 14, 2014, the Court of Appeal released two decisions with respect to proceedings commenced pursuant to section 8 of the Patented Medicines Regulations.
March 24, 2014
Globalisation increasingly requires that employers send employees abroad; such travel can vary greatly from short business trips to longer-term postings.
March 21, 2014
The US Food and Drug Administration (“FDA”) is attempting to reduce...
March 20, 2014
Over the past year, there were a number of notable developments in matters relating to branding and naming of pharmaceutical products in Canada.
March 17, 2014
This case concerns a proposed generic version of the brand name drug PATADAY, an eye drop solution used to treat allergic and inflammatory eye reactions.
This legal update summarizes the key trends and provides tips for investment fund issuers.
March 14, 2014
Pipeline projects present challenges that other energy projects do not present. Pipelines can run long distances.
March 12, 2014
Try searching our global site instead